News Articles on Tigris Pharmaceuticals, Inc.

First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418

BONITA SPRINGS, Fla., May 1 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that dosing ha
http://www.bioportfolio.com/news/First_Patient_Dosed_in_Phase_I_Clinical_Trial_of.html - Friday May 1 2009

Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting

BONITA SPRINGS, Fla., April 30 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, announced that preclinical
http://www.bioportfolio.com/news/Tigris_Pharmaceuticals_Presents_Results_of_Breast.html - Thursday April 30 2009

Tigris Pharmaceuticals Appoints Pedro Granadillo as Chairman of Board of Directors

BONITA SPRINGS, Fla., April 16 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held company developing targeted cancer treatment therapie
http://www.bioportfolio.com/news/Tigris_Pharmaceuticals_Appoints_Pedro_Granadillo.html - Thursday April 16 2009

FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418

BONITA SPRINGS, Fla., March 4 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, today announced that its Inv
http://www.bioportfolio.com/news/FDA_Accepts_Investigational_New_Drug_%28IND%29.html - Wednesday March 4 2009

Tigris Pharmaceuticals Files IND Application for GGTI-2418

BONITA SPRINGS, Fla., Feb. 6 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it has f
http://www.bioportfolio.com/news/Tigris_Pharmaceuticals_Files_IND_Application_for.html - Friday February 6 2009